Barclays PLC (NYSE:BCS) Given Average Rating of “Hold” by Analysts

Share on StockTwits

Shares of Barclays PLC (NYSE:BCS) have been assigned a consensus recommendation of “Hold” from the seven research firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have given a buy recommendation to the company.

Several equities research analysts have recently commented on BCS shares. Bank of America downgraded Barclays from a “buy” rating to a “neutral” rating in a report on Thursday, April 18th. Zacks Investment Research raised Barclays from a “sell” rating to a “hold” rating in a report on Thursday, May 2nd.

Shares of NYSE BCS traded up $0.11 during trading hours on Friday, hitting $7.55. The company had a trading volume of 62,436 shares, compared to its average volume of 2,210,098. The stock has a market capitalization of $32.19 billion, a PE ratio of 6.51, a P/E/G ratio of 2.76 and a beta of 0.92. The company has a debt-to-equity ratio of 5.01, a current ratio of 1.51 and a quick ratio of 1.51. Barclays has a 1-year low of $7.07 and a 1-year high of $10.48. The firm’s 50 day moving average price is $7.76.

Barclays (NYSE:BCS) last released its quarterly earnings data on Thursday, April 25th. The financial services provider reported $0.33 EPS for the quarter, beating the consensus estimate of $0.31 by $0.02. The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.97 billion. Barclays had a return on equity of 5.51% and a net margin of 15.73%. Equities research analysts expect that Barclays will post 1.17 EPS for the current year.

A number of institutional investors have recently made changes to their positions in the business. Dimensional Fund Advisors LP lifted its holdings in Barclays by 7.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 14,443,537 shares of the financial services provider’s stock valued at $108,904,000 after purchasing an additional 980,953 shares during the last quarter. Deutsche Bank AG increased its position in Barclays by 9,565.4% during the 4th quarter. Deutsche Bank AG now owns 5,282,341 shares of the financial services provider’s stock worth $39,828,000 after buying an additional 5,227,689 shares during the period. Parametric Portfolio Associates LLC increased its position in Barclays by 26.3% during the 1st quarter. Parametric Portfolio Associates LLC now owns 4,271,115 shares of the financial services provider’s stock worth $34,169,000 after buying an additional 888,209 shares during the period. Brandes Investment Partners LP increased its position in Barclays by 15.0% during the 1st quarter. Brandes Investment Partners LP now owns 3,653,430 shares of the financial services provider’s stock worth $29,227,000 after buying an additional 476,187 shares during the period. Finally, Raymond James & Associates increased its position in Barclays by 10.7% during the 1st quarter. Raymond James & Associates now owns 2,795,481 shares of the financial services provider’s stock worth $22,364,000 after buying an additional 271,096 shares during the period. 2.57% of the stock is owned by institutional investors and hedge funds.

Barclays Company Profile

Barclays PLC, through its subsidiaries, provides various financial products and services in the United Kingdom, other European countries, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK and Barclays International divisions. It offers personal and business banking services; credit and debit cards; international banking; and private banking services, which include investment, wealth planning, and credit and specialist solutions to high net worth and ultra-high net worth clients, and family offices.

Recommended Story: Net Income

Analyst Recommendations for Barclays (NYSE:BCS)

Receive News & Ratings for Barclays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barclays and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Elastic  Rating Lowered to Sell at Zacks Investment Research
Elastic Rating Lowered to Sell at Zacks Investment Research
Diplomat Pharmacy  Stock Rating Lowered by Zacks Investment Research
Diplomat Pharmacy Stock Rating Lowered by Zacks Investment Research
Dicerna Pharmaceuticals  Rating Lowered to Sell at Zacks Investment Research
Dicerna Pharmaceuticals Rating Lowered to Sell at Zacks Investment Research
Eastgroup Properties  Rating Lowered to Hold at Zacks Investment Research
Eastgroup Properties Rating Lowered to Hold at Zacks Investment Research
Zacks Investment Research Upgrades NOW  to “Buy”
Zacks Investment Research Upgrades NOW to “Buy”
Zacks Investment Research Downgrades Endologix  to Hold
Zacks Investment Research Downgrades Endologix to Hold


© 2006-2019 Ticker Report